theralpha

Theralpha developpe des medicaments antidouleurs (50Milliars€) de nouvelle génération pour des malades non stabilisés par les médicaments conventionnels....

  • Stage Concept Only
  • Industry Biotechnology
  • Location Nice, PACA, France
  • Currency EUR
  • Founded March 2009
  • Employees 1
  • Website theralpha.com

Company Summary

Theralpha developpe des medicaments antidouleurs (50Milliars€) de nouvelle génération pour des malades non stabilisés par les médicaments conventionnels.

Team

  • David Dellamonica
    CEO

    Since its inception in 2009, David Dellamonica is the founding CEO of Theralpha, a French leading biotech start-up involved in the pain management drugs (4). Between 1998 and 2009, he developed a successful track record in Market Access, Business Development, Licensing and Alliances management exclusively in the field of life sciences and healthcare leading him in 2007 to VP Business & Corporate Development at Txcell. David holds a MS in Manageme

  • Marc Vasseur
    President

  • Michel Lazdunski
    President MSAB

  • David Dellamonica

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free